예측 검사 및 증상전 검사 시장은 2023-2028년 25억 9,470만 달러로 예측 기간 동안 10.03%의 CAGR로 성장할 것으로 예상됩니다. 이 보고서는 예측 검사 및 증상전 검사 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.
현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 전 세계 의료비 지출 증가, 유전 상담에 대한 수요 증가, 유전성 질환의 조기 검진에 대한 인식이 높아지면서 시장을 주도하고 있습니다.
| 시장 범위 |
| 기준 연도 |
2024년 |
| 종료 연도 |
2028년 |
| 예측 기간 |
2024-2028년 |
| 성장 모멘텀 |
가속 |
| 전년 대비[2024년] |
8.88% |
| CAGR |
10.03% |
| 증분 금액 |
25억 9,470만 달러 |
이 보고서는 향후 몇 년 동안 예측 검사 및 증상전 검사 시장의 성장을 촉진하는 주요 요인 중 하나로 유전성 질환의 유병률 증가를 꼽았습니다. 또한, 유전성 질환의 조기 검진에 대한 인식의 증가와 유전자 검사 기술의 발전은 시장의 큰 수요로 이어질 것입니다.
목차
제1장 주요 요약
제2장 시장 상황
제3장 시장 규모 평가
- 시장 정의
- 시장 부문 분석
- 시장 규모 2023년
- 시장 전망 2023-2028년
제4장 시장 규모 실적
- 예측 검사 및 증상전 검사 세계 시장 2018-2022년
- 용도별 부문 분석 2018-2022년
- 지역별 부문 분석 2018-2022년
- 국가별 부문 분석 2018-2022년
제5장 Five Forces 분석
- Five Forces 요약
- 구매자의 교섭력
- 공급 기업의 교섭력
- 신규 참여업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 상황
제6장 시장 세분화 : 용도별
- 시장 세분화
- 비교 : 용도별
- 암 질환 : 시장 규모와 예측 2023-2028년
- 유전성 질환 : 시장 규모와 예측 2023-2028년
- 심혈관 질환 : 시장 규모와 예측 2023-2028년
- 시장 기회 : 용도별
제7장 고객 상황
제8장 지역별 상황
- 지역별 세분화
- 비교 : 지역별
- 북미 : 시장 규모와 예측 2023-2028년
- 유럽 : 시장 규모와 예측 2023-2028년
- 아시아 : 시장 규모와 예측 2023-2028년
- 기타 : 시장 규모와 예측 2023-2028년
- 미국 : 시장 규모와 예측 2023-2028년
- 독일 : 시장 규모와 예측 2023-2028년
- 일본 : 시장 규모와 예측 2023-2028년
- 영국 : 시장 규모와 예측 2023-2028년
- 프랑스 : 시장 규모와 예측 2023-2028년
- 시장 기회 : 지역 상황별
제9장 촉진요인, 과제, 기회, 억제요인
- 시장 성장 촉진요인
- 시장 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회·억제요인
제10장 경쟁 상황
제11장 경쟁 분석
- 기업 개요
- 기업의 시장 포지셔닝
- Abbott Laboratories
- Color Health Inc.
- Direct Laboratory Services LLC
- Healius Ltd.
- Mapmygenome India Ltd.
- myDNA Life Ltd.
- Myriad Genetics Inc.
- Quest Diagnostics Inc.
- Sysmex Corp.
제12장 부록
ksm
The predictive presymptomatic testing market is forecasted to grow by USD 2594.7 mn during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the predictive presymptomatic testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing healthcare spending worldwide, increasing demand for genetic counseling, and rise in awareness toward early screening of genetic disorders.
Technavio's predictive presymptomatic testing market is segmented as below:
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 8.88% |
| CAGR | 10.03% |
| Incremental Value | $2594.7 mn |
By Application
- Cancer diseases
- Genetic diseases
- Cardiovascular diseases
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing prevalence of genetic diseases as one of the prime reasons driving the predictive presymptomatic testing market growth during the next few years. Also, rise in awareness toward early screening of genetic disorders and advancements in genetic testing techniques will lead to sizable demand in the market.
The report on the predictive presymptomatic testing market covers the following areas:
- Predictive presymptomatic testing market sizing
- Predictive presymptomatic testing market forecast
- Predictive presymptomatic testing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading predictive presymptomatic testing market vendors that include 23andMe Holding Co., Abbott Laboratories, Amgen Inc., BioAxis DNA Research Centre P Ltd., Color Health Inc., Deep Genomics Inc., Direct Laboratory Services LLC, DNA and U, Editas Medicine Inc., Healius Ltd., Illumina Inc., International Business Machines Corp., Mapmygenome India Ltd., myDNA Life Ltd., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Inc., Sysmex Corp., and Veritas Genetics Inc.. Also, the predictive presymptomatic testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
- 2.3 Value chain analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Predictive Presymptomatic Testing Market 2018 - 2022
- Historic Market Size - Data Table on Global Predictive Presymptomatic Testing Market 2018 - 2022 ($ million)
- 4.2 Application segment analysis 2018 - 2022
- Historic Market Size - Application Segment 2018 - 2022 ($ million)
- 4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
- 6.1 Market segments
- Chart on Application - Market share 2023-2028 (%)
- Data Table on Application - Market share 2023-2028 (%)
- 6.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 6.3 Cancer diseases - Market size and forecast 2023-2028
- Chart on Cancer diseases - Market size and forecast 2023-2028 ($ million)
- Data Table on Cancer diseases - Market size and forecast 2023-2028 ($ million)
- Chart on Cancer diseases - Year-over-year growth 2023-2028 (%)
- Data Table on Cancer diseases - Year-over-year growth 2023-2028 (%)
- 6.4 Genetic diseases - Market size and forecast 2023-2028
- Chart on Genetic diseases - Market size and forecast 2023-2028 ($ million)
- Data Table on Genetic diseases - Market size and forecast 2023-2028 ($ million)
- Chart on Genetic diseases - Year-over-year growth 2023-2028 (%)
- Data Table on Genetic diseases - Year-over-year growth 2023-2028 (%)
- 6.5 Cardiovascular diseases - Market size and forecast 2023-2028
- Chart on Cardiovascular diseases - Market size and forecast 2023-2028 ($ million)
- Data Table on Cardiovascular diseases - Market size and forecast 2023-2028 ($ million)
- Chart on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
- Data Table on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
- 6.6 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
7 Customer Landscape
- 7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
- 8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 8.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 8.9 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 8.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 8.11 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
- 8.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
- 9.1 Market drivers
- 9.2 Market challenges
- 9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 9.4 Market opportunities/restraints
10 Competitive Landscape
- 10.1 Overview
- 10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 10.3 Landscape disruption
- Overview on factors of disruption
- 10.4 Industry risks
- Impact of key risks on business
11 Competitive Analysis
- 11.1 Companies profiled
- 11.2 Market positioning of companies
- Matrix on companies position and classification
- 23andMe Holding Co.
- 23andMe Holding Co. - Overview
- 23andMe Holding Co. - Business segments
- 23andMe Holding Co. - Key offerings
- 23andMe Holding Co. - Segment focus
- 11.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- 11.5 Color Health Inc.
- Color Health Inc. - Overview
- Color Health Inc. - Product / Service
- Color Health Inc. - Key offerings
- 11.6 Direct Laboratory Services LLC
- Direct Laboratory Services LLC - Overview
- Direct Laboratory Services LLC - Product / Service
- Direct Laboratory Services LLC - Key offerings
- 11.7 Healius Ltd.
- Healius Ltd. - Overview
- Healius Ltd. - Product / Service
- Healius Ltd. - Key offerings
- 11.8 Mapmygenome India Ltd.
- Mapmygenome India Ltd. - Overview
- Mapmygenome India Ltd. - Product / Service
- Mapmygenome India Ltd. - Key offerings
- 11.9 myDNA Life Ltd.
- myDNA Life Ltd. - Overview
- myDNA Life Ltd. - Product / Service
- myDNA Life Ltd. - Key offerings
- 11.10 Myriad Genetics Inc.
- Myriad Genetics Inc. - Overview
- Myriad Genetics Inc. - Product / Service
- Myriad Genetics Inc. - Key news
- Myriad Genetics Inc. - Key offerings
- 11.11 Quest Diagnostics Inc.
- Quest Diagnostics Inc. - Overview
- Quest Diagnostics Inc. - Business segments
- Quest Diagnostics Inc. - Key offerings
- Quest Diagnostics Inc. - Segment focus
- 11.12 Sysmex Corp.
- Sysmex Corp. - Overview
- Sysmex Corp. - Business segments
- Sysmex Corp. - Key offerings
- Sysmex Corp. - Segment focus
12 Appendix
- 12.1 Scope of the report
- 12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 12.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 12.4 Research methodology
- 12.5 Data procurement
- 12.6 Data validation
- 12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 12.8 Data synthesis
- 12.9 360 degree market analysis
- 360 degree market analysis
- 12.10 List of abbreviations
